Last reviewed · How we verify
MultiStem high dose
At a glance
| Generic name | MultiStem high dose |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome (PHASE1, PHASE2)
- Study to Examine the Effects of MultiStem in Ischemic Stroke (PHASE2)
- A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MultiStem high dose CI brief — competitive landscape report
- MultiStem high dose updates RSS · CI watch RSS
- Pfizer portfolio CI